AU2015370419B2 - Method of culturing segmented filamentous bacteria in vitro - Google Patents

Method of culturing segmented filamentous bacteria in vitro Download PDF

Info

Publication number
AU2015370419B2
AU2015370419B2 AU2015370419A AU2015370419A AU2015370419B2 AU 2015370419 B2 AU2015370419 B2 AU 2015370419B2 AU 2015370419 A AU2015370419 A AU 2015370419A AU 2015370419 A AU2015370419 A AU 2015370419A AU 2015370419 B2 AU2015370419 B2 AU 2015370419B2
Authority
AU
Australia
Prior art keywords
sfb
strain
antigen
culturing
intimin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2015370419A
Other languages
English (en)
Other versions
AU2015370419A1 (en
Inventor
David Bikard
Nadine CERF BENSUSSAN
Gerard Eberl
Valerie Gaboriau-Routhiau
Philippe Sansonetti
Pamela SCHNUPF
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Assistance Publique - Hôpitaux de Paris
Institut National de la Santé et de la Recherche Médicale
Fondation Imagine
Université Paris Cité
Institut Pasteur
Original Assignee
Assistance Publique - Hôpitaux de Paris
Institut National de la Santé et de la Recherche Médicale
Fondation Imagine
Université Paris Cité
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Assistance Publique - Hôpitaux de Paris, Institut National de la Santé et de la Recherche Médicale, Fondation Imagine, Université Paris Cité, Institut Pasteur filed Critical Assistance Publique - Hôpitaux de Paris
Publication of AU2015370419A1 publication Critical patent/AU2015370419A1/en
Application granted granted Critical
Publication of AU2015370419B2 publication Critical patent/AU2015370419B2/en
Assigned to INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), INSTITUT PASTEUR, ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS, FONDATION IMAGINE, UNIVERSITÉ PARIS CITÉ reassignment INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) Request for Assignment Assignors: ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS, FONDATION IMAGINE, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), INSTITUT PASTEUR, UNIVERSITE PARIS DESCARTES
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/23—Gastro-intestinal tract cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2015370419A 2014-12-23 2015-12-23 Method of culturing segmented filamentous bacteria in vitro Active AU2015370419B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPCT/IB2014/067285 2014-12-23
PCT/IB2014/067285 WO2016103005A1 (en) 2014-12-23 2014-12-23 Method of culturing segmented filamentous bacteria in vitro
PCT/IB2015/059948 WO2016103217A1 (en) 2014-12-23 2015-12-23 Method of culturing segmented filamentous bacteria in vitro

Publications (2)

Publication Number Publication Date
AU2015370419A1 AU2015370419A1 (en) 2017-08-03
AU2015370419B2 true AU2015370419B2 (en) 2021-12-23

Family

ID=52462962

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2015370419A Active AU2015370419B2 (en) 2014-12-23 2015-12-23 Method of culturing segmented filamentous bacteria in vitro

Country Status (6)

Country Link
US (2) US10435665B2 (cg-RX-API-DMAC7.html)
EP (1) EP3237602B1 (cg-RX-API-DMAC7.html)
JP (1) JP6963999B2 (cg-RX-API-DMAC7.html)
CN (1) CN107429222B (cg-RX-API-DMAC7.html)
AU (1) AU2015370419B2 (cg-RX-API-DMAC7.html)
WO (2) WO2016103005A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016103005A1 (en) * 2014-12-23 2016-06-30 Institut Pasteur Method of culturing segmented filamentous bacteria in vitro
CN106011281B (zh) * 2016-07-19 2019-04-23 浙江大学 肠道分节丝状菌鞭毛蛋白的检测方法
DE102018213030A1 (de) * 2018-08-03 2020-02-06 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Behandlung von Immunerkrankungen durch die antikörpervermittelte Neutralisierung spezifischer Darmbakterien
WO2021155229A1 (en) * 2020-01-31 2021-08-05 Iowa State University Research Foundation, Inc. Gut bacterium-based treatment to increase poultry gut health and food safety
CA3218163A1 (en) 2021-05-17 2022-11-24 Anne PALERMO Food product comprising a co-culture of bacteria and fungi
WO2026011048A1 (en) * 2024-07-03 2026-01-08 Ohio State Innovation Foundation Commensal bacterial antigen as a therapeutic agent for cancers

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011046616A2 (en) * 2009-10-15 2011-04-21 New York University Methods for modulating bacterial infection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2556835B1 (en) * 2010-02-10 2015-08-05 Japan Eco-Science Co. Ltd. Mixture, dissolving solution and pharmaceutical agent each comprising thermophilic microorganism
MX369877B (es) 2013-02-04 2019-11-25 Seres Therapeutics Inc Composiciones y metodos.
WO2016103005A1 (en) * 2014-12-23 2016-06-30 Institut Pasteur Method of culturing segmented filamentous bacteria in vitro

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011046616A2 (en) * 2009-10-15 2011-04-21 New York University Methods for modulating bacterial infection

Also Published As

Publication number Publication date
JP6963999B2 (ja) 2021-11-10
JP2018505666A (ja) 2018-03-01
US20170335276A1 (en) 2017-11-23
EP3237602B1 (en) 2020-06-10
WO2016103005A1 (en) 2016-06-30
WO2016103217A1 (en) 2016-06-30
EP3237602A1 (en) 2017-11-01
US20190367867A1 (en) 2019-12-05
CN107429222B (zh) 2021-06-15
CA2971933A1 (en) 2016-06-30
US11725183B2 (en) 2023-08-15
AU2015370419A1 (en) 2017-08-03
CN107429222A (zh) 2017-12-01
US10435665B2 (en) 2019-10-08

Similar Documents

Publication Publication Date Title
CN107429222B (zh) 在体外培养分节丝状菌的方法
AU2015373129B2 (en) Methods of transdifferentiation and methods of use thereof
AU2020273293A1 (en) Compositions and methods for induction of Th17 cells
AU2024205703A1 (en) Wheat stem rust resistance genes and methods of use
ES2280758T5 (es) Vectores sitio-específicos de integración en listeria y procedimientos para la utilización de los mismos.
CN111349596B (zh) 产褪黑素的重组大肠杆菌及其构建方法和应用
KR20200064980A (ko) 종양 세포에서 면역 조절제 및 항-암 치료제를 생산하도록 프로그램된 미생물
KR20140101890A (ko) 3-히드록시이소부티르산의 생명공학적 제조
DK2468861T3 (en) A method for constructing carrier for gene transport
CN116806259A (zh) 痤疮丙酸杆菌重组噬菌体、其产生方法和用途
EP2597151A2 (en) Recombinant microorganisms, methods for preparing vaccine strains, antigens, and vector vaccine compositions of same, uses thereof, and related antibodies, diagnostic kit, and treatment and/or prophylactic methods
CN114746549A (zh) 加快细胞内生物学设计的模块化、无细胞蛋白质表达载体
KR102967320B1 (ko) 신규한 재조합 뉴캣슬바이러스벡터 및 이를 포함하는 백신 조성물
WO2020169221A1 (en) Production of plant-based active substances (e.g. cannabinoids) by recombinant microorganisms
CN110669710B (zh) 重组乳酸乳球菌和罗非鱼无乳链球菌病疫苗
CN106868029A (zh) 防龋转基因植物疫苗及其制备方法
CN113999317B (zh) 激发机体抗非洲猪瘟感染的融合基因及其编码蛋白和应用
CN100564533C (zh) 一种高效表达病毒基因dsRNA的载体及其应用
CN112195190A (zh) 来源于贝莱斯芽孢杆菌质粒的复制元件及其应用
Lee et al. Development of a gene delivery system in Streptococcus gordonii using thymidylate synthase as a selection marker
CN111388658B (zh) 基于重组减毒李斯特菌的kras高表达癌症疫苗及其制备方法及其应用方法
CA2971933C (en) Method of culturing segmented filamentous bacteria in vitro
HK1234318B (en) Compositions and methods for induction of th17 cells
HK1234318A1 (en) Compositions and methods for induction of th17 cells

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: UNIVERSITE PARIS CITE

Free format text: FORMER OWNER(S): FONDATION IMAGINE; INSTITUT PASTEUR; UNIVERSITE PARIS DESCARTES; ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS; INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)

Owner name: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)

Free format text: FORMER OWNER(S): FONDATION IMAGINE; INSTITUT PASTEUR; UNIVERSITE PARIS DESCARTES; ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS; INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)

Owner name: ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS

Free format text: FORMER OWNER(S): FONDATION IMAGINE; INSTITUT PASTEUR; UNIVERSITE PARIS DESCARTES; ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS; INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)

Owner name: FONDATION IMAGINE

Free format text: FORMER OWNER(S): FONDATION IMAGINE; INSTITUT PASTEUR; UNIVERSITE PARIS DESCARTES; ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS; INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)

Owner name: INSTITUT PASTEUR

Free format text: FORMER OWNER(S): FONDATION IMAGINE; INSTITUT PASTEUR; UNIVERSITE PARIS DESCARTES; ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS; INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)